MX354947B - Metodo para preparar una composicion a base de acido hialuronico. - Google Patents
Metodo para preparar una composicion a base de acido hialuronico.Info
- Publication number
- MX354947B MX354947B MX2014015133A MX2014015133A MX354947B MX 354947 B MX354947 B MX 354947B MX 2014015133 A MX2014015133 A MX 2014015133A MX 2014015133 A MX2014015133 A MX 2014015133A MX 354947 B MX354947 B MX 354947B
- Authority
- MX
- Mexico
- Prior art keywords
- preparing
- polymer
- hyaluronic acid
- composition based
- crosslinked
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0059—Cosmetic or alloplastic implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Anesthesiology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a un método para preparar una composición, la composición que comprende un primer polímero reticulado, opcionalmente un segundo polímero, que puede estar reticulado o no reticulado, y agua, en donde el primero y el segundo polímero se seleccionan a partir de un polisacárido, que comprende al menos los pasos (i) a (iv) (i) reticular una mezcla que comprende el primer polímero y agua; (ii) subsiguiente a la reticulación en el paso (i), terminar la reticulación; (iii) mezclar opcionalmente el producto obtenido en el paso (ii) con el segundo polímero; (iv) someter el producto obtenido en el paso (iii) a diálisis.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261660269P | 2012-06-15 | 2012-06-15 | |
EP12004962 | 2012-07-04 | ||
EP13000961 | 2013-02-26 | ||
PCT/EP2013/001782 WO2013185934A1 (en) | 2012-06-15 | 2013-06-14 | Method of preparing a composition based on hyaluronic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014015133A MX2014015133A (es) | 2015-03-05 |
MX354947B true MX354947B (es) | 2018-03-27 |
Family
ID=49757607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014015133A MX354947B (es) | 2012-06-15 | 2013-06-14 | Metodo para preparar una composicion a base de acido hialuronico. |
Country Status (20)
Country | Link |
---|---|
US (1) | US9822223B2 (es) |
EP (1) | EP2861626B1 (es) |
JP (1) | JP6174690B2 (es) |
KR (2) | KR20150022934A (es) |
CN (1) | CN104395348B (es) |
AR (1) | AR091454A1 (es) |
AU (1) | AU2013276844B2 (es) |
BR (1) | BR112014031412B1 (es) |
CA (1) | CA2876070C (es) |
HK (1) | HK1205750A1 (es) |
IL (1) | IL235918B (es) |
IN (1) | IN2014DN10147A (es) |
LT (1) | LT2861626T (es) |
MX (1) | MX354947B (es) |
PL (1) | PL2861626T3 (es) |
RU (1) | RU2640911C2 (es) |
SG (1) | SG11201408312UA (es) |
TW (1) | TWI605834B (es) |
WO (1) | WO2013185934A1 (es) |
ZA (1) | ZA201409155B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR099900A1 (es) | 2014-04-01 | 2016-08-24 | Merz Pharma Gmbh & Co Kgaa | Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso |
FR3029928B1 (fr) * | 2014-12-15 | 2018-03-09 | Teoxane | Gel reticule |
WO2017001057A1 (en) * | 2015-06-30 | 2017-01-05 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing a composition based on hyaluronic acid |
US10836840B2 (en) * | 2015-06-30 | 2020-11-17 | Merz Pharma Gmbh & Co. Kgaa | Method for producing crosslinked hyaluronic acid |
EP3320028A1 (en) * | 2015-09-01 | 2018-05-16 | Merz Pharma GmbH & Co. KGaA | Method of making a cross-linked polymer gel and device for performing the method |
TWI727014B (zh) | 2016-03-24 | 2021-05-11 | 德商梅茲製藥有限兩合公司 | 修飾透明質酸與其製造方法及其用途 |
EP3535031B1 (en) | 2016-11-03 | 2024-04-10 | Merz Pharma GmbH & Co. KGaA | Method for preparing hyaluronic acid dermal fillers, dermal fillers obtained thereby and their use |
EP3354258A1 (en) * | 2017-01-31 | 2018-08-01 | Teoxane SA | Use of a cohesive gel as a matrix material in a periodontal pocket |
EP3743079A1 (en) * | 2018-02-06 | 2020-12-02 | Regen Lab SA | Cross-linked hyaluronic acids and combinations with prp/bmc |
US20210260244A1 (en) | 2018-06-29 | 2021-08-26 | Merz Pharma Gmbh & Co. Kgaa | Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof |
WO2020030629A1 (en) | 2018-08-07 | 2020-02-13 | Merz Pharma Gmbh & Co. Kgaa | Method for dynamic filtration of a cross-linked hydrogel |
WO2021116069A1 (en) | 2019-12-09 | 2021-06-17 | Merz Pharma Gmbh & Co. Kgaa | Process for producing a composition comprising a crosslinked hydrogel |
CN112940300B (zh) * | 2019-12-10 | 2023-03-31 | 爱博诺德(北京)医疗科技股份有限公司 | 交联透明质酸凝胶的制备方法 |
WO2021115310A1 (zh) * | 2019-12-10 | 2021-06-17 | 爱博诺德(北京)医疗科技股份有限公司 | 交联透明质酸凝胶及其制备方法 |
FR3111903B1 (fr) | 2020-06-24 | 2022-12-02 | Lab Vivacy | Procede d’incorporation de composes organiques en solution au sein d’un hydrogel |
WO2023101838A1 (en) * | 2021-12-03 | 2023-06-08 | Pawel Slusarewicz | Method of fecal sample preparation for automated image analysis |
TW202333793A (zh) | 2022-01-11 | 2023-09-01 | 義大利商Gpq有限公司 | 作為創新填充劑之新玻尿酸衍生物 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4713448A (en) | 1985-03-12 | 1987-12-15 | Biomatrix, Inc. | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues |
DE3636590A1 (de) | 1986-10-28 | 1988-05-26 | Braun Melsungen Ag | Blutersatzmittel |
US5143724A (en) * | 1990-07-09 | 1992-09-01 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
US5248772A (en) * | 1992-01-29 | 1993-09-28 | Coulter Corporation | Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
US5827937A (en) * | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US8124120B2 (en) | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
BRPI0418309B8 (pt) * | 2003-12-30 | 2021-05-25 | Genzyme Corp | "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis". |
FR2865737B1 (fr) * | 2004-02-03 | 2006-03-31 | Anteis Sa | Gel reticule biocompatible |
US20050226936A1 (en) * | 2004-04-08 | 2005-10-13 | Q-Med Ab | Method of soft tissue augmentation |
EP1818344A4 (en) | 2004-11-15 | 2012-04-18 | Shiseido Co Ltd | METHOD FOR SYNTHESIZING RETICULATED HYALURONIC ACID GEL |
EP1891941A1 (en) | 2006-08-11 | 2008-02-27 | OctoPlus Technologies B.V. | Aqueous gels comprising microspheres |
FR2909560B1 (fr) | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
WO2008139122A2 (fr) | 2007-05-11 | 2008-11-20 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
WO2009021526A1 (de) | 2007-07-25 | 2009-02-19 | S & V Technologies Ag | Hyaluronsäuredispersion, herstellung und anwendung |
US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
FR2919999B1 (fr) | 2007-08-13 | 2010-01-29 | Oreal | Compositions d'acide hyaluronique |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
FR2924615B1 (fr) * | 2007-12-07 | 2010-01-22 | Vivacy Lab | Hydrogel cohesif biodegradable. |
FR2927255B1 (fr) | 2008-02-07 | 2011-08-12 | Keysan Consulting | Produits injectables biocompatibles a liberation de zinc et/ou de sel de saccharide sous forme de zinc et leurs utilisations. |
US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
WO2010105900A1 (en) | 2009-03-16 | 2010-09-23 | Thomson Licensing | Exponentiation method resistant against side-channel and safe-error attacks |
AU2010232547A1 (en) * | 2009-04-02 | 2011-10-27 | Allergan, Inc. | Hair-like shaped hydrogels for soft tissue augmentation |
IT1395392B1 (it) * | 2009-08-27 | 2012-09-14 | Fidia Farmaceutici | Geli viscoelastici come nuovi filler |
US8691279B2 (en) | 2010-03-22 | 2014-04-08 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
ES2637202T3 (es) * | 2010-11-08 | 2017-10-11 | Allergan Industrie, Sas | Formulaciones a base de ácido hialurónico |
-
2013
- 2013-06-14 IN IN10147DEN2014 patent/IN2014DN10147A/en unknown
- 2013-06-14 JP JP2015516514A patent/JP6174690B2/ja active Active
- 2013-06-14 KR KR20147037159A patent/KR20150022934A/ko active Application Filing
- 2013-06-14 CA CA2876070A patent/CA2876070C/en active Active
- 2013-06-14 RU RU2015101105A patent/RU2640911C2/ru active
- 2013-06-14 AR ARP130102107 patent/AR091454A1/es active IP Right Grant
- 2013-06-14 US US14/407,231 patent/US9822223B2/en active Active
- 2013-06-14 AU AU2013276844A patent/AU2013276844B2/en active Active
- 2013-06-14 EP EP13731292.2A patent/EP2861626B1/en active Active
- 2013-06-14 BR BR112014031412-8A patent/BR112014031412B1/pt active IP Right Grant
- 2013-06-14 SG SG11201408312UA patent/SG11201408312UA/en unknown
- 2013-06-14 WO PCT/EP2013/001782 patent/WO2013185934A1/en active Application Filing
- 2013-06-14 PL PL13731292T patent/PL2861626T3/pl unknown
- 2013-06-14 CN CN201380031602.7A patent/CN104395348B/zh active Active
- 2013-06-14 KR KR1020187032298A patent/KR20180122758A/ko active Search and Examination
- 2013-06-14 LT LTEP13731292.2T patent/LT2861626T/lt unknown
- 2013-06-14 MX MX2014015133A patent/MX354947B/es active IP Right Grant
- 2013-06-17 TW TW102121431A patent/TWI605834B/zh active
-
2014
- 2014-11-26 IL IL235918A patent/IL235918B/en active IP Right Grant
- 2014-12-12 ZA ZA2014/09155A patent/ZA201409155B/en unknown
-
2015
- 2015-07-03 HK HK15106346.1A patent/HK1205750A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IN2014DN10147A (es) | 2015-08-21 |
RU2015101105A (ru) | 2016-08-10 |
CN104395348A (zh) | 2015-03-04 |
PL2861626T3 (pl) | 2019-05-31 |
TWI605834B (zh) | 2017-11-21 |
TW201404409A (zh) | 2014-02-01 |
JP6174690B2 (ja) | 2017-08-02 |
AU2013276844A1 (en) | 2014-12-18 |
CA2876070A1 (en) | 2013-12-19 |
BR112014031412B1 (pt) | 2021-01-05 |
SG11201408312UA (en) | 2015-01-29 |
CA2876070C (en) | 2021-01-26 |
US9822223B2 (en) | 2017-11-21 |
ZA201409155B (en) | 2015-11-25 |
CN104395348B (zh) | 2019-07-30 |
JP2015526537A (ja) | 2015-09-10 |
EP2861626B1 (en) | 2018-12-19 |
AR091454A1 (es) | 2015-02-04 |
IL235918B (en) | 2018-11-29 |
WO2013185934A1 (en) | 2013-12-19 |
US20150232623A1 (en) | 2015-08-20 |
LT2861626T (lt) | 2019-01-25 |
EP2861626A1 (en) | 2015-04-22 |
RU2640911C2 (ru) | 2018-01-12 |
BR112014031412A2 (pt) | 2017-06-27 |
HK1205750A1 (en) | 2015-12-24 |
AU2013276844B2 (en) | 2017-09-28 |
MX2014015133A (es) | 2015-03-05 |
IL235918A0 (en) | 2015-01-29 |
KR20150022934A (ko) | 2015-03-04 |
KR20180122758A (ko) | 2018-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014015133A (es) | Metodo para preparar una composicion a base de acido hialuronico. | |
PH12018500719A1 (en) | Oligonucleotide compositions and methods thereof | |
BR112018010585A2 (pt) | composições de betume compreendendo lignina | |
WO2017017433A3 (en) | Graphene membrane | |
WO2013060769A3 (en) | Hemostatic compositions | |
UA106570C2 (uk) | Суміші полімолочної кислоти й розчинного у воді полімеру | |
WO2011073341A3 (de) | Polymerdispersionen | |
EP3110879A4 (en) | Crosslinked polymer, method for producing the same, molecular sieve composition and material separation membranes | |
PL3538066T3 (pl) | Wypełniacze skórne z kwasem hialuronowym usieciowane kwasem cytrynowym, sposób ich wytwarzania i ich zastosowania | |
EP3131145A4 (en) | Polymer electrolyte composition and polymer electrolyte membrane, membrane-electrolyte assembly, and solid polymer fuel cell using same | |
WO2014095794A3 (en) | Polyaryl ether polymers end-capped with phenolic amino acids | |
EP3159365A4 (en) | Cyclopentene ring-opening polymer and method for producing same, polymer composition, and polymer crosslinked product | |
EP3270449A4 (en) | Composite polymer electrolyte membrane, as well as electrolyte membrane having catalyst layer, membrane electrode assembly, and solid polymer fuel cell in which said composite polymer electrolyte membrane is used | |
MX2015004624A (es) | Membranas de polianilina, usos y métodos relacionados con éstas. | |
PH12015500774B1 (en) | Melt processed polymer composition derived from leaf sheaths of trees of the genus arecaceae | |
WO2012087327A3 (en) | Polymer systems | |
EP3614472A4 (en) | CATALYST FOR SOLID POLYMER ELECTROLYTE FUEL CELLS AND PROCESS FOR PRODUCING THE SAME | |
EP3258523A4 (en) | Separator for solid polymer fuel cell and method for producing same | |
WO2010138958A3 (en) | Ionomers and methods of making same and uses thereof | |
EP3385269A4 (en) | Organic-inorganic hybrid perovskite, method for preparing same, and solar cell comprising same | |
EP3125349A4 (en) | Polymer electrolyte membrane, and membrane-electrode assembly and fuel cell containing same | |
EP3312203A4 (en) | Method for preparing rubber composition using aminosilane-based terminal modifying agent having functional group introduced therein, and rubber composition prepared thereby | |
EP3355395A4 (en) | MEMBRANE ELECTRODE ARRANGEMENT FOR FUEL CELL, METHOD FOR THE MANUFACTURE THEREOF AND FUEL CELL SYSTEM THEREWITH | |
KR101881386B1 (ko) | 폴리머 블렌드를 포함하는 연료전지용 전해질 막, 및 이를 포함하는 막-전극 접합체 및 연료전지 | |
PH12015502693A1 (en) | A composition, process and a kit for sugar processing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |